ALVO Alvotech
NEUTRAL
Impact: 3/10
PRESS-RELEASE
Press release: earnings
Latest settled — T+20d ⚠ clustered
ALVO ▲ 0.00% at T+20d
NEUTRAL call ✗ call lost 0.00% · α vs SPY -4.03% · entry $3.38 → $3.38
Currently $4.16 · +23.08% from $3.38 entry
T+1d
-2.37%
call -2.37% · α -2.53%
$3.30
settled 6w ago
T+5d
-1.18%
call -1.18% · α -2.09%
$3.34
settled 6w ago
T+20d
0.00%
call 0.00% · α -4.03%
$3.38
settled 19d ago
T+60d
—
call — · α —
—
in 6w
Price Chart
Loading chart...
Executive Summary
Alvotech announced it will release Q1 2026 financial results on May 6, 2026, with a webcast and Q&A on May 7. No financial results were reported in this press release — it is a forward-looking announcement only.
Actionable Insight
Monitor the May 6 earnings release and May 7 webcast for Q1 2026 financials, particularly cash runway and progress on biosimilar commercialization, given recent history of large EPS misses.
Key Facts
- Alvotech will release Q1 2026 financial results on May 6, 2026, after market close.
- Webcast and live Q&A scheduled for May 7, 2026, at 08:00 ET.
- No financial results were disclosed in this press release.
- Event is routine and informational, consistent with prior quarterly reporting cadence.
Financial Impact
No financial data reported
Risk Factors
- Risk of another significant earnings miss based on recent trends (last 4 quarters averaged -191% EPS surprise).
- High cash burn and lack of profitability remain key concerns for this pre-profit biotech.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3280781 |
10 reports for ALVO
50%
Hit rate
best @ T+20▲ +1.88%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
1d ago
|
Press Release
| $3.55 awaiting T+1 | awaiting T+1 | — | $4.16 (+17.35%) |
|
Jun 8, 2026
1d ago
|
Press Release
| $3.55 awaiting T+1 | awaiting T+1 | — | $4.16 (+17.35%) |
|
Jun 4, 2026
5d ago
|
Press Release
| $3.74 $3.54 | ▼ −5.35% | ▼ −2.75% | $4.16 (+11.23%) |
|
May 11, 2026
29d ago
|
Press Release
| $3.59 $3.55 | ▼ −1.11% | ▼ −0.98% | $4.16 (+15.88%) |
|
May 11, 2026
29d ago
|
Press Release
| $3.59 $3.55 | ▼ −1.11% | ▼ −0.98% | $4.16 (+15.88%) |
|
May 6, 2026
4w ago
|
Press Release
| $3.20 $3.20 | · 0.00% | ▲ +0.83% | $4.16 (−30.00%) |
|
May 6, 2026
4w ago
|
Press Release
| $3.20 $3.20 | · 0.00% | ▲ +0.83% | $4.16 (−30.00%) |
|
Apr 24, 2026
6w ago
|
Press Release
| $3.38 $3.30 | ▼ −2.37% | ▼ −2.53% | $4.16 (+23.08%) |
|
Apr 24, 2026
6w ago
|
Press Release
| $3.38 $3.30 | ▼ −2.37% | ▼ −2.53% | $4.16 (+23.08%) |
|
Mar 4, 2026
13w ago
|
Press Release
| $3.89 $4.16 | ▲ +6.94% | ▲ +7.51% | $4.16 (+6.94%) |
Showing 10 of 10
US Market Status
Market Closed — Opens Thu (11h 17m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access